๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The pharmacology of oral agents used to treat diabetes mellitus

โœ Scribed by Chan, A W ;Macfarlane, I A


Publisher
John Wiley and Sons
Year
1988
Tongue
English
Weight
860 KB
Volume
5
Category
Article
ISSN
1357-8170

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Pravastatin compared to bezafibrate in t
โœ C. Rustemeijer; J. A. Schouten; H. J. Voerman; H. E. S. J. Hensgens; A. J. M. Do ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 99 KB ๐Ÿ‘ 2 views

Background Both HMG-CoA reductase inhibitors and ยฎbric acid derivates are used for the treatment of dyslipidemia in Type 2 diabetes patients. The aim of this study was to compare the lipid lowering effect of 40 mg pravastatin, a HMG-CoA reductase inhibitor, and 400 mg bezaยฎbrate, a ยฎbric acid deriva

Multicentre study to assess quality of l
โœ Barnett, AH ;Jones, D Bowen ;Burden, AC ;Janes, JM ;Sinclair, A ;Small, M ;Tinda ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 530 KB

## Abstract Quality of life, glycaemic control and frequency of hypoglycaemia were compared in 93 moderate to poorly controlled Type 2 diabetes patients randomly allocated to one of three treatment groups: Group A continued on oral hypoglycaemics, Group B switched to twiceโ€daily fixed mixture of hu